The lung proteome in HIV-associated obstructive lung disease (OLD)

• Published in: ERJ open research p. 204
• Main Authors: Samorodnitsky, Sarah, Weise, Danielle, Lock, Eric F., Kunisaki, Ken M., Morris, Alison, Leung, Janice M., Kruk, Monica, Parker, Laurie, Jagtap, Pratik, Griffin, Timothy J., Wendt, Chris H.
• Format: Journal Article
• Language: English
• Published: 27.09.2024
• ISSN: 2312-0541; 2312-0541
• DOI: 10.1183/23120541.00204-2024

Rationale Obstructive lung disease is increasingly common among persons living with HIV (PLWH). There are currently no validated biomarkers that identify individuals at risk of developing obstructive lung disease (OLD) and specific mechanisms contributing to HIV-associated OLD remain elusive, independent of smoking. Objectives We sought to identify biomarkers and biological pathways associated with OLD using a broad proteomic approach. Methods We performed tandem mass tagging and mass spectrometry (MS) analysis on bronchoalveolar lavage fluid (BALF) samples from persons living with HIV with OLD (n=26) and without OLD (n=26). We combined untargeted MS with a targeted SomaScan aptamer-based approach. We used Pearson correlation tests to identify associations between each protein and lung function (FEV1pp). We adjusted for multiple comparisons using a false discovery rate (FDR) adjustment. Significant proteins were entered into a pathway overrepresentation analysis. Protein-driven endotypes were constructed using K-means clustering. Measurements and main results We identified over 3800 proteins by MS and identified 254 proteins that correlated with FEV1pp when we combined the MS and SomaScan proteomes when adjusting for smoking status. Pathway analysis revealed cell adhesion molecules as significant. Conclusions Protein expression differs in the lung of PWH and decreased lung function (FEV1pp). Pathway analysis reveals cell adhesion molecules having potentially important roles in this process.